Replies to post #117219 on Biotech Values

[CHM_760]

Biotech Stocks Could See Action On Valeant (VRX) Bid for Cephalon (CEPH): (BIIB) (JAZZ) (DNDN) (REGN) (more...)
5:46 pm ET 03/29/2011- StreetInsider
Biotech stocks could see a bid tonight and tomorrow following Valeant Pharmaceuticals (NYSE: VRX) $73 per share bid for Cephalon, Inc. (Nasdaq: CEPH).

Here is a list of biotech companies mentioned as takeover targets in the past:Biogen Idec Inc. (Nasdaq: BIIB), Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ), Dendreon Corp. (Nasdaq: DNDN), Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN), Human Genome Sciences Inc. (Nasdaq: HGSI), Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX), Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN), Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), ONYX Pharmaceuticals Inc. (Nasdaq: ONXX).
.

[10nisman]

CEPH

*DJ Cephalon Also Confirms Bid From Another Unnamed Party
*DJ Cephalon Says Working With Advisors To Review, Consider Bids
*DJ Cephalon Says Will Respond To Valeant Bid During Apr 4 Week